Kevin F. Hanley - Net Worth and Insider Trading
Kevin F. Hanley Net Worth
The estimated net worth of Kevin F. Hanley is at least $212,000 dollars as of 2024-11-13. Kevin F. Hanley is the See Remarks of Ocular Therapeutix Inc and owns about 20,000 shares of Ocular Therapeutix Inc (OCUL) stock worth over $212,000. Details can be seen in Kevin F. Hanley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin F. Hanley has not made any transactions after 2018-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kevin F. Hanley
Kevin F. Hanley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin F. Hanley owns 1 companies in total, including Ocular Therapeutix Inc (OCUL) .
Click here to see the complete history of Kevin F. Hanley’s form 4 insider trades.
Insider Ownership Summary of Kevin F. Hanley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2018-12-14 | Sr. V.P. & Technical Operations |
Kevin F. Hanley Latest Holdings Summary
Kevin F. Hanley currently owns a total of 1 stock. Kevin F. Hanley owns 20,000 shares of Ocular Therapeutix Inc (OCUL) as of December 14, 2018, with a value of $212,000.
Latest Holdings of Kevin F. Hanley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCUL | Ocular Therapeutix Inc | 2018-12-14 | 20,000 | 10.60 | 212,000 |
Holding Weightings of Kevin F. Hanley
Kevin F. Hanley Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin F. Hanley has made a total of 0 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years. The most-recent trade in Ocular Therapeutix Inc is the acquisition of 10,000 shares on December 14, 2018, which cost Kevin F. Hanley around $55,000.
Insider Trading History of Kevin F. Hanley
- 1
Kevin F. Hanley Trading Performance
GuruFocus tracks the stock performance after each of Kevin F. Hanley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin F. Hanley is -23.33%. GuruFocus also compares Kevin F. Hanley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin F. Hanley within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin F. Hanley's insider trading performs compared to the benchmark.
Performance of Kevin F. Hanley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.33 | | | | | |
| Relative Return to S&P 500(%) | -26.21 | | | | | |
Kevin F. Hanley Ownership Network
Ownership Network List of Kevin F. Hanley
Ownership Network Relation of Kevin F. Hanley
Kevin F. Hanley Owned Company Details
What does Ocular Therapeutix Inc do?
Who are the key executives at Ocular Therapeutix Inc?
Kevin F. Hanley is the Sr. V.P. & Technical Operations of Ocular Therapeutix Inc. Other key executives at Ocular Therapeutix Inc include 10 percent owner Summer Road Llc , Chief Business Officer Christopher G White , and Chief Financial Officer Donald Notman .
Ocular Therapeutix Inc (OCUL) Insider Trades Summary
Over the past 18 months, Kevin F. Hanley made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 31,480 shares made by Antony C. Mattessich , a net sale of 14,942 shares made by Rabia Gurses Ozden , and a net purchase of 2,469,312 shares made by Summer Road Llc .
In summary, during the past 3 months, insiders sold 22,712 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 22,712 shares. During the past 18 months, 136,096 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,339,716 shares.
Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocular Therapeutix Inc Insider Transactions
Kevin F. Hanley Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin F. Hanley. You might contact Kevin F. Hanley via mailing address: C/o Ocular Therapeutix, Inc., 15 Crosby Drive, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
